Nanosuspension: An approach to enhance solubility of drugs

被引:493
作者
Patel, Vishal R. [1 ]
Agrawal, Y. K. [1 ]
机构
[1] Gujarat Forens Sci Univ, Inst Res & Dev, Sector 18-A,B-H Police Bhavan, Gandhinagar 382007, Gujarat, India
关键词
Bioavailability; colloidal dispersion; drug delivery; nanosuspension; solubility;
D O I
10.4103/2231-4040.82950
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
One of the major problems associated with poorly soluble drugs is very low bioavailability. The problem is even more complex for drugs like itraconazole, simvastatin, and carbamazepine which are poorly soluble in both aqueous and nonaqueous media, belonging to BCS class II as classified by biopharmaceutical classification system. Formulation as nanosuspension is an attractive and promising alternative to solve these problems. Nanosuspension consists of the pure poorly water-soluble drug without any matrix material suspended in dispersion. Preparation of nanosuspension is simple and applicable to all drugs which are water insoluble. A nanosuspension not only solves the problems of poor solubility and bioavailability, but also alters the pharmacokinetics of drug and thus improves drug safety and efficacy. This review article describes the preparation methods, characterization, and applications of the nanosuspension.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 49 条
[1]   Nanosuspension technology and its applications in drug delivery [J].
Arunkumar, N. ;
Deecaraman, M. ;
Rani, C. .
ASIAN JOURNAL OF PHARMACEUTICS, 2009, 3 (03) :168-173
[2]   SOLVENT SELECTION IN THE PREPARATION OF POLY(DL-LACTIDE) MICROSPHERES PREPARED BY THE SOLVENT EVAPORATION METHOD [J].
BODMEIER, R ;
MCGINITY, JW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 43 (1-2) :179-186
[3]   ULTRA-LONG-DURATION LOCAL-ANESTHESIA PRODUCED BY INJECTION OF LECITHIN-COATED TETRACAINE MICROCRYSTALS [J].
BOEDEKER, BH ;
LOJESKI, EW ;
KLINE, MD ;
HAYNES, DH .
JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (06) :699-702
[4]   Differential scanning calorimetry and scanning thermal microscopy analysis of pharmaceutical materials [J].
Bond, L ;
Allen, S ;
Davies, MC ;
Roberts, CJ ;
Shivji, AP ;
Tendler, SJB ;
Williams, PM ;
Zhang, JX .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 243 (1-2) :71-82
[5]   Oleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effect [J].
Chen, YJ ;
Liu, J ;
Yang, XL ;
Zhao, XL ;
Xu, HB .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (02) :259-264
[6]  
DEARN AR, 2000, Patent No. 6018080
[7]  
GASSMANN P, 1994, EUR J PHARM BIOPHARM, V40, P64
[8]   Nanosuspensions of poorly soluble drugs -: reproducibility of small scale production [J].
Grau, MJ ;
Kayser, O ;
Müller, RH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 196 (02) :155-159
[9]   Characterization of nebulized buparvaquone nanosuspensions -: effect of nebulization technology [J].
Hernández-Trejo, N ;
Kayser, O ;
Steckel, H ;
Müller, RH .
JOURNAL OF DRUG TARGETING, 2005, 13 (8-9) :499-507
[10]   Spectroscopic approach for on-line monitoring of particle size during the processing of pharmaceutical nanoparticles [J].
Higgins, JP ;
Arrivo, SM ;
Thurau, G ;
Green, RL ;
Bowen, W ;
Lange, A ;
Templeton, AC ;
Thomas, DL ;
Reed, RA .
ANALYTICAL CHEMISTRY, 2003, 75 (08) :1777-1785